Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04948190Unknown

Canine COVID-19 Detection Phase 2 and 3

Role: lead

NCT04509713Unknown

Canine COVID-19 Detection

Role: lead

NCT03708120Not ApplicableCompleted

Determining the Complete Protection Time of an Insect Repellent With 30% Citriodiol® Against Three Species of Ticks.

Role: lead

NCT04028180Not ApplicableCompleted

Comparison Trial Between Two Repellent Products and a Positive Control Against Culicoides Nubeculosus Midges

Role: lead

All 4 trials loaded